
|Videos|June 26, 2020
Clinical Ramifications of Pneumococcal Vaccine Development
Author(s)Contagion® Editorial Staff
Dr. Luwy Musey, executive director in biologics, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Advertisement
Segment Description: Dr. Luwy Musey, executive director in biologics, vaccine clinical research, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Part 1: Developments in Pneumococcal Conjugate Vaccines
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Reductions in Funding, Personnel Will Leave US Less Prepared for Future Infectious Disease Outbreaks
2
Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311
3
ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections
4
Challenges to Adopting New Therapeutics: Familiarity, Diagnostics, and Real-World Use in Persistent Bacteremia
5









































































































































































